The results of diethylstilboestrol therapy for recurrent and metastatic carcinoma of the male breast.
dc.contributor.author | Ribeiro, G | |
dc.date.accessioned | 2011-06-23T16:49:18Z | |
dc.date.available | 2011-06-23T16:49:18Z | |
dc.date.issued | 1976-04 | |
dc.identifier.citation | The results of diethylstilboestrol therapy for recurrent and metastatic carcinoma of the male breast. 1976, 33 (4):465-7 Br J Cancer | en |
dc.identifier.issn | 0007-0920 | |
dc.identifier.pmid | 1268034 | |
dc.identifier.uri | http://hdl.handle.net/10541/134331 | |
dc.description.abstract | A retrospective survey has been made of 58 patients with recurrent and advanced male breast cancer treated with oral diethylstilboestrol. Fifty-five patients were suitable for assessment. Fourteen patients had an objective response and 7 had a partial response giving a total response of 21/55 patients (38%). The median remission for the objective responders was 7 years. Three patients are alive and free of disease; one has now been in remission for 13 years. It is suggested that diethylstilboestrol is a useful treatment in patients with soft tissue disease (breast, chest wall and/or lymph nodes). | |
dc.language.iso | en | en |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Bone Neoplasms | |
dc.subject.mesh | Breast Neoplasms | |
dc.subject.mesh | Diethylstilbestrol | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Lung Neoplasms | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Neoplasm Metastasis | |
dc.subject.mesh | Neoplasm Recurrence, Local | |
dc.subject.mesh | Retrospective Studies | |
dc.title | The results of diethylstilboestrol therapy for recurrent and metastatic carcinoma of the male breast. | en |
dc.type | Article | en |
dc.contributor.department | Department of Radiotherapy, The Christie Hospital & Holt Radium Institute, Manchester | en |
dc.identifier.journal | British Journal of Cancer | en |
dc.identifier.pmcid | PMC2025078 | |
html.description.abstract | A retrospective survey has been made of 58 patients with recurrent and advanced male breast cancer treated with oral diethylstilboestrol. Fifty-five patients were suitable for assessment. Fourteen patients had an objective response and 7 had a partial response giving a total response of 21/55 patients (38%). The median remission for the objective responders was 7 years. Three patients are alive and free of disease; one has now been in remission for 13 years. It is suggested that diethylstilboestrol is a useful treatment in patients with soft tissue disease (breast, chest wall and/or lymph nodes). |